alendronate has been researched along with trinitrobenzenesulfonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballester, I; Daddaoua, A; López-Posadas, R; Martínez-Augustin, O; Nieto, A; Sánchez de Medina, F; Suárez, MD; Zarzuelo, A | 1 |
| González, R; López-Posadas, R; Martínez-Augustin, O; Mascaraque, C; Sánchez de Medina, F; Suárez, MD; Zarzuelo, A | 1 |
2 other study(ies) available for alendronate and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
The bisphosphonate alendronate improves the damage associated with trinitrobenzenesulfonic acid-induced colitis in rats.
Topics: Administration, Oral; Alendronate; Animals; Anti-Inflammatory Agents; Body Weight; Bone Density Conservation Agents; Chemokine CCL2; Colitis; Colon; Diphosphonates; Dose-Response Relationship, Drug; Female; Gastrointestinal Agents; Gene Expression; Injections, Intraperitoneal; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Rats; Rats, Wistar; Sulfasalazine; Treatment Outcome; Trinitrobenzenesulfonic Acid | 2007 |
The Bisphosphonate Pamidronate is an Intestinal Antiinflammatory Agent in Rat and Mouse Experimental Colitis.
Topics: Alendronate; Animals; Anti-Inflammatory Agents; Colitis; Dextran Sulfate; Diphosphonates; Ibandronic Acid; Immunologic Factors; Intestinal Mucosa; Mice; Pamidronate; Rats; T-Lymphocytes; Trinitrobenzenesulfonic Acid | 2016 |